🔎 Trials Near Me

Akèy › Melanom › Missouri

Etid klinik pou Melanom nan Missouri

22 etid pou Melanom ap chèche patisipan nan sit nan Missouri.

Vil nan Missouri

Tèks ofisyèl etid la (Anglè)

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Washington University, School of Medicine, St Louis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  • VA St. Louis Healthcare System, St Louis
  • Washington University School of Medicine, St Louis
  • Mercy South, St Louis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06246916

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Saint Francis Medical Center, Cape Girardeau
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • ak 4 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196

Pan-tumor MRD Study

  • Cox Health, Springfield
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

  • University of Kansas Cancer Center - Briarcliff, Kansas City
  • University of Kansas Cancer Center - North, Kansas City
  • University of Kansas Cancer Center - Lee's Summit, Lee's Summit
Ap rekriteFaz 3
Laj 75 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07068074

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

  • Washington University School of Medicine, St Louis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06529822

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  • Washington University, St Louis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05267626

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Saint Louis Cancer and Breast Institute-Ballwin, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • ak 19 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04511013

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • ak 21 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT05334069

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • Washington University School of Medicine, St Louis
  • ak 2 plis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT05896839

Project: Every Child for Younger Patients With Cancer

  • University of Missouri Children's Hospital, Columbia
  • Children's Mercy Hospitals and Clinics, Kansas City
  • Cardinal Glennon Children's Medical Center, St Louis
  • ak 2 plis
Ap rekriteEtid obsèvasyon
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Washington University School of Medicine, St Louis
Ap rekriteFaz 1/2
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, St Louis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07115043

IDOV-Immune for Advanced Solid Tumors

  • Washington University School of Medicine, St Louis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06910657

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Institute, East, Kansas City
  • Saint Luke's Cancer Institute, Kansas City
  • Saint Luke's Cancer Institute, Kansas City North, Kansas City
  • ak 3 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

  • Mercy Hospital - SPG, Springfield
  • Mercy Hospital - South, St Louis
  • Mercy Hospital -STL, St Louis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT07327489

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

  • Saint Louis University Hospital, St Louis
  • Washington University of St. Louis, St Louis
Ap rekriteFaz 1/2
Laj 18 a 90 · Tout sèks · Mizajou Jun 10, 2026 · NCT05655312

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Saint Louis Cancer and Breast Institute-Ballwin, Ballwin
  • Parkland Health Center - Farmington, Farmington
  • ak 16 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

  • Washington University School of Medicine, St Louis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2026 · NCT05549297

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

  • Washington University School of Medicine, St Louis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 20, 2026 · NCT04354064

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Kansas City
  • Massive Bio SYNERGY-AI site, St Louis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • Siteman Cancer Centre, Barnes Jewish West County, Creve Coeur
  • University of Kansas Cancer Center, Kansas City
  • Cox South Hospital, Springfield
  • ak 1 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Nov 27, 2024 · NCT03860883

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.